About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Brain Cancer Clinical Trials in Los Angeles | 53 Studies

Clinical Trials Brain CancerLos Angeles

Brain Cancer Clinical Trials in Los Angeles

Find 53 clinical trials for brain cancer near Los Angeles, California. Connect with research centers in your area.

All Brain Cancer trials nationwide All trials in Los Angeles

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 53 trials

TerminatedVAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBMThis is an adaptive design, randomized controlled, Phase 3 clinical trial in patients with glioblastoma multiforme (GBM) or gliosarcoma (GS), previously treated with surgery (if…NCT03149575·Los Angeles, California and 4 others CompletedPhase I Study of APX005M in Pediatric Central Nervous System TumorsThis phase I trial studies the side effects and best dose of APX005M in treating younger patients with primary malignant central nervous system tumor that is growing, spreading…NCT03389802·Los Angeles, California and 10 others

Brain Cancer Trials in Other Cities

New York Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedTesting Ramipril to Prevent Memory Loss in People With GlioblastomaThis study is to determine if an oral drug called Ramipril can lower the chance of memory loss in patients with glioblastoma getting chemoradiation.NCT03475186·Anchorage, Alaska and 422 others

TerminatedPalbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System TumorsThis phase I trial studies the side effects and best dose of palbociclib isethionate in treating younger patients with central nervous system tumors that have grown, come back, or…NCT02255461·Los Angeles, California and 10 others

CompletedPazopanib in Treating Patients With Recurrent GlioblastomaThis phase II trial is studying the side effects and how well pazopanib works in treating patients with recurrent glioblastoma.NCT00459381·Los Angeles, California and 8 others

CompletedChemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord TumorsRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003141·Duarte, California and 70 others

RecruitingTesting the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous TreatmentThis phase I/II trial tests the safety, side effects and best dose of selinexor given in combination with the usual chemotherapy (temozolomide) and compares the effect of this…NCT05432804·Phoenix, Arizona and 38 others

TerminatedVaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by SurgeryThis randomized phase II trial studies how well giving vaccine therapy with or without bevacizumab works in treating patients with recurrent glioblastoma multiforme that can be…NCT01814813·Anchorage, Alaska and 416 others

CompletedErlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive MeningiomaPhase I/II trial to study the effectiveness of erlotinib in treating patients who have recurrent malignant glioma or recurrent or progressive meningioma.NCT00045110·Los Angeles, California and 6 others

CompletedA Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive GlioblastomaThe purpose of this research study is to find out whether adding an experimental vaccine called rindopepimut (also known as CDX-110) to the commonly used drug bevacizumab can…NCT01498328·Birmingham, Alabama and 44 others

TerminatedRO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant GliomaThis phase I/II trial is studying the side effects and the best dose of RO4929097 to see how well it works when given together with bevacizumab compared to bevacizumab alone in…NCT01189240·Los Angeles, California and 3 others

CompletedFR901228 in Treating Patients With Recurrent High-Grade GliomasThis phase I/II trial is studying the side effects and best dose of FR901228 and to see how well it works in treating patients with recurrent high-grade gliomas.NCT00085540·Los Angeles, California and 7 others

TerminatedA Phase 2 Study of PLX3397 in Patients With Recurrent GlioblastomaThe objective of this study is to evaluate the response of subjects with recurrent glioblastoma to continuous therapy of PLX3397.NCT01349036·Los Angeles, California and 5 others

RecruitingSafety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP LossThis is a first in human study of TNG456 alone and in combination with abemaciclib in patients with advanced or metastatic solid tumors known to have an MTAP loss.NCT06810544·Scottsdale, Arizona and 14 others

CompletedA Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including NeuroblastomaThe study's purpose is to see if the drug, abemaciclib, is safe and effective when given with other drugs to kill cancer cells.NCT04238819·Phoenix, Arizona and 24 others

CompletedDendritic Cell Vaccine for Patients With Brain TumorsThe main purpose of this study is to evaluate the most effective immunotherapy vaccine components in patients with malignant glioma.NCT01204684·Los Angeles, California

CompletedCellular Immunotherapy Study for Brain CancerThe purpose of this research study to determine if treating recurrent malignant gliomas with another person's (donor) immune system cells known as aCTL cells, will be safe.NCT01144247·Los Angeles, California

CompletedA Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) AmplificationThis study seeks to determine whether the addition of ABT-414 to concomitant radiotherapy and temozolomide (TMZ) followed by combination of ABT-414 with adjuvant TMZ prolongs…NCT02573324·Phoenix, Arizona and 211 others

CompletedSelinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade GliomasThis phase I trial studies the side effects and best dose of selinexor in treating younger patients with solid tumors or central nervous system (CNS) tumors that have come back…NCT02323880·Birmingham, Alabama and 22 others

CompletedBortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaRATIONALE: Bortezomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.NCT00998010·Los Angeles, California

Page 1 of 3Next

Other Conditions in Los Angeles

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia